Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
[Compensatory mechanisms in multiple sclerosis(review)].
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Distribution Patterns of 18F-Labelled Fluoromethylcholine in Normal Structures and Tumors of the Head: A PET/MRI Evaluation.
Long-term daily vibration exposure alters current perception threshold (CPT) sensitivity and myelinated axons in a rat-tail model of vibration-induced injury.
The Choroid Plexus in Healthy and Diseased Brain.
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »